EUVIMEDEUVIMED entdecken
Crossref

Fluorescent‐protein co‐expression to select CHO cells expressing high quantities of vaccine antigens

Jishna Ganguly, Fu Zongming, Marion James, Yan Pan, John Ruano, Michael Dahle, Xiangming Li iD

Biotechnology Journal · 2024

DOI: 10.1002/biot.202300671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Jishna Ganguly und 6 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Cricetulus, Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell line development for production of vaccine antigens or therapeutic proteins typically involves transfection, selection, and enrichment for high‐expressing cells. Enrichment methods include minipool enrichment, antibody‐based enrichment, and enrichment based on co‐expressed fluorescent biosensor proteins. However, these methods have limitations regarding labor and cost intensity, the generation of antibodies and assurance of their viral safety, and potential expression‐interference or signal‐saturation of the co‐expressed fluorescent protein. To improve the method of fluorescent‐protein co‐expression, expression constructs were created that constitutively express a model vaccine antigen together with one of three fluorescent proteins having translation initiation controlled by a wildtype or mutant internal ribosome entry site (IRES), for a total of six constructs. The constructs were transfected into Chinese hamster ovary cells (CHO) cells, enriched for high fluorescence, cultured, and tested in a mini bioreactor to identify the most promising construct. The fluorescent protein, Fluorescent Ubiquitination‐based Cell Cycle Indicator (FUCCI) with a mutant IRES performed best and was further tested with three additional vaccine antigens. Across the four vaccine antigens, the FUCCI fluorescent protein yielded productivity enhancements, without the need for generating an antibody and assuring its viral safety. Furthermore, FUCCI protein was present in negligible quantities in the cell supernatant, indicating a low risk for contaminating drug substances or vaccine antigen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CricetulusVaccinesCHO CellsAnimalsLuminescent ProteinsAntigensTransfectionBioreactorsCricetinae

Stichwörter der Autor:innen

CHO cellsbiosensorcell line developmentfluorescent protein co‐expressionvaccine antigens

Substanzen

VaccinesLuminescent ProteinsAntigens

Autor:innen und Institutionen

  • GSK, Rockville, Maryland, USA.

ORCID-Profile: Xiangming Li

Zitieren

APA

Ganguly, J., Zongming, F., James, M., Pan, Y., Ruano, J., Dahle, M., & Li, X. (2024). Fluorescent‐protein co‐expression to select CHO cells expressing high quantities of vaccine antigens. Biotechnology Journal. https://doi.org/10.1002/biot.202300671

Vancouver

Ganguly J, Zongming F, James M, Pan Y, Ruano J, Dahle M, et al. Fluorescent‐protein co‐expression to select CHO cells expressing high quantities of vaccine antigens. Biotechnology Journal. 2024. doi:10.1002/biot.202300671

BibTeX
@article{Ganguly2024,
  author = {Ganguly, Jishna and Zongming, Fu and James, Marion and Pan, Yan and Ruano, John and Dahle, Michael and Li, Xiangming},
  title = {Fluorescent‐protein co‐expression to select CHO cells expressing high quantities of vaccine antigens},
  journal = {Biotechnology Journal},
  year = {2024},
  doi = {10.1002/biot.202300671}
}
Kostenlos starten →